Steve Pawsey
InvestorGrowth Partner at Advent Life Sciences
Find your path to Steve
33 people in our graph can introduce you to Steve.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Shahzad Malik to introduce you to Steve
You →Shahzad · together at Advent Life Sciences →Steve
Ask Jamie Chen to introduce you to Steve
You →Jamie · 11 people · together at Advent Life Sciences →Steve
Sign up to find every way you can get introduced to Steve
- Your email: the people you already email who know Steve
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Steve
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Dr Steve Pawsey is a pharmaceutical physician with over 30 years of drug development experience across pharma and biotech. He joined Advent as a Growth Partner in early 2026, having previously served as CMO of two Advent portfolio companies, including KaNDy Therapeutics, where he oversaw development of elinzanetant (Lynkuet) ahead of its acquisition by Bayer. He trained in medicine at the University of London, initially in anaesthesia and critical care, and is a Fellow of the Faculty of Pharmaceutical Medicine.
Invests in
Biotech
Colleagues at Advent Life Sciences
Frequently asked questions
- Who is Steve Pawsey?
- Dr Steve Pawsey is a pharmaceutical physician with over 30 years of drug development experience across pharma and biotech. He joined Advent as a Growth Partner in early 2026, having previously served as CMO of two Advent portfolio companies, including KaNDy Therapeutics, where he oversaw development of elinzanetant (Lynkuet) ahead of its acquisition by Bayer. He trained in medicine at the University of London, initially in anaesthesia and critical care, and is a Fellow of the Faculty of Pharmaceutical Medicine.
- Where does Steve Pawsey work?
- Steve Pawsey is Growth Partner at Advent Life Sciences.
- What does Steve Pawsey invest in?
- Steve Pawsey invests in Biotech.








